Cue Biopharma, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $27.5 | $9.3 | $5.5 | $1.2 | $14.9 |
| Operating income | -$26.6 | -$41.5 | -$52.1 | -$53.2 | -$43.7 |
| Net income | -$26.6 | -$40.7 | -$50.7 | -$53.0 | -$44.2 |
| Balance Sheet | |||||
| Total debt | — | — | $8.0 | $10.0 | — |
| Cash Flow Statement | |||||
| Free cash flow | -$21.9 | -$36.4 | -$40.0 | -$42.0 | -$39.8 |
| Share repurchases | — | — | $0.0 | $0.2 | $0.8 |
Shares outstanding 7.3M · Free float 57.8%
Annual filing data through FY ended December 31, 2025; float as of September 11, 2026.